Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites

Details for Australian Patent Application No. 2005313387 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Kruse, Cornelis G.; Van Hes, Roelof; Tulp, Martinus Th. M.; Smid, Pieter

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005313387

PCT Pub. Number WO2006/061373

Priority 04106351.2 07.12.04 EP; 60/633,439 07.12.04 US

Filing date 6 December 2005

Wipo publication date 15 June 2006

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/061373 Priority application(s): WO2006/061373

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313388-Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites

2005313386-Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites